Accession | ARO:3005017 |
Definition | LMB is an AMR Gene family belonging to subclass B3 metallo-beta-lactamases. |
Drug Class | carbapenem, cephalosporin, penam |
Resistance Mechanism | antibiotic inactivation |
Classification | 12 ontology terms | Show + process or component of antibiotic biology or chemistry + mechanism of antibiotic resistance + determinant of antibiotic resistance + antibiotic inactivation [Resistance Mechanism] + antibiotic inactivation enzyme + hydrolysis of antibiotic conferring resistance + antibiotic molecule + hydrolysis of beta-lactam antibiotic by metallo-beta-lactamase + beta-lactam antibiotic + beta-lactamase + cephem + class B (metallo-) beta-lactamase |
Parent Term(s) | 4 ontology terms | Show + confers_resistance_to_drug_class carbapenem [Drug Class] + confers_resistance_to_drug_class cephalosporin [Drug Class] + confers_resistance_to_drug_class penam [Drug Class] + subclass B3 (metallo-) beta-lactamase |
Sub-Term(s) | 1 ontology terms | Show + LMB-1 |
Publications | Dabos L, et al. 2020. Int. J. Antimicrob. Agents 55(2):105857 LMB-1 producing Citrobacter freundii from Argentina, a novel player in the field of MBLs. (PMID 31785341) |